Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis. (Q50955712)
Jump to navigation
Jump to search
scientific article published in September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis. |
scientific article published in September 2013 |
Statements
1 reference
Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis. (English)
1 reference
1 reference
M Simrén
1 reference
R Dahlén
1 reference
H Strid
1 reference
A Lundgren
1 reference
S Isaksson
1 reference
S Raghavan
1 reference
M K Magnusson
1 reference
H Sjövall
1 reference
1 September 2013
1 reference
78
1 reference
3
1 reference
275-284
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference